Table 1 (abstract P2095). Demographic features and treatment response during anakinra therapy
From: 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Patient ID # | Age | Sex | Diagnosis | Duration of pericarditisfollow-up (mo) | Prior medications | Number of recurrences before anakinra | Anakinra treatment duration (mo) | Time to corticosteroid discontinuation (mo) | Number of recurrences after daily dose of anakinra |
|---|---|---|---|---|---|---|---|---|---|
1* | 23 | M | IRP | 129 | Colchicine, NSAIDs, CS, HCQ | 6 | 52 | 9 | No |
2 | 32 | F | IRP | 128 | Colchicine, NSAIDs | 7 | 4 | NA | No |
3* | 40 | F | IRP | 21 | Colchicine, CS | 6 | 8 | 1 | No |
4 | 20 | M | IRP | 11 | Colchicine, CS | 3 | 8 | 2 | No |
5 | 25 | M | FMF | 30 | Colchicine, CS | 5 | 15 | 1 | No |